Español
India
Italiano
Français
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
Español
India
Italiano
Français
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Covey Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Staar Surgical
(NASDAQ:STAA)
Intraday
$45.60
0.91
[2.04%]
After-Hours
$45.60
0
[0.00%]
Get Report
Watch
Perks
Buy
Compare Brokers
$45.60
0.91
[2.04%]
At close: May 2
$45.60
0
[0.00%]
After Hours: 5:30PM EDT
Get Report
Watch
Q1 2024 Earnings in 5 days from now on Tue May 7th, after the market close
Overview
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest News for Staar Surgical Stock (NASDAQ:STAA)
Staar Surgical Stock (NASDAQ: STAA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, April 11, 2024
Apple To $210? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
-
Apr 11, 2024, 8:31AM
Mizuho Maintains Buy on Staar Surgical, Raises Price Target to $53
Benzinga Newsdesk
-
Apr 11, 2024, 7:39AM
Monday, April 08, 2024
Canaccord Genuity Maintains Hold on Staar Surgical, Raises Price Target to $46
Benzinga Newsdesk
-
Apr 8, 2024, 7:47AM
Friday, April 05, 2024
STAAR Surgical shares are trading higher after the company recently issued strong preliminary Q1 net sales guidance.
Benzinga Newsdesk
-
Apr 5, 2024, 3:50PM
Thursday, April 04, 2024
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Vandana Singh
-
Apr 4, 2024, 1:54PM
Why STAAR Surgical Shares Are Trading Higher By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Avi Kapoor
-
Apr 4, 2024, 1:21PM
In-Depth Examination Of 4 Analyst Recommendations For Staar Surgical
Benzinga Insights
-
Apr 4, 2024, 12:00PM
Needham Reiterates Hold on Staar Surgical
Benzinga Newsdesk
-
Apr 4, 2024, 9:35AM
Market-Moving News for April 4th
Benzinga Newsdesk
-
Apr 4, 2024, 8:33AM
STAAR Surgical shares are trading higher after the company issued strong preliminary Q1 net sales guidance.
Benzinga Newsdesk
-
Apr 4, 2024, 7:15AM
STAAR Surgical Reports Preliminary Net Sales For Q1 To Be In Excess Of $77M (Est $72.134M); Now Expects FY24 Net Sales Can Be At Higher End Of Prior Outlook Range Of $335M-$340M (Est $337.208M)
Benzinga Newsdesk
-
Apr 4, 2024, 7:11AM
Monday, April 01, 2024
Stifel Maintains Buy on Staar Surgical, Maintains $50 Price Target
Benzinga Newsdesk
-
Apr 1, 2024, 11:06AM
Monday, March 11, 2024
Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Avi Kapoor
-
Mar 11, 2024, 1:41PM
Staar Surgical shares are trading higher after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.
Benzinga Newsdesk
-
Mar 11, 2024, 9:25AM
Netflix To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Monday
Avi Kapoor
-
Mar 11, 2024, 8:16AM
Stifel Upgrades Staar Surgical to Buy, Raises Price Target to $50
Benzinga Newsdesk
-
Mar 11, 2024, 4:57AM
Wednesday, February 28, 2024
Mizuho Maintains Buy on Staar Surgical, Lowers Price Target to $45
Benzinga Newsdesk
-
Feb 28, 2024, 9:07AM
Tuesday, February 27, 2024
Piper Sandler Maintains Neutral on Staar Surgical, Lowers Price Target to $33
Benzinga Newsdesk
-
Feb 27, 2024, 10:30AM
Monday, February 26, 2024
STAAR Surgical Company Sees FY24 Adjusted EBITDA Of ~$36M And Adjusted EBITDA Per Diluted Share Of ~$0.70
Benzinga Newsdesk
-
Feb 26, 2024, 4:03PM
Staar Surgical Q4 EPS $0.16 Misses $0.17 Estimate, Sales $76.27M Beat $75.89M Estimate
Happy Mohamed
-
Feb 26, 2024, 4:02PM
Earnings Scheduled For February 26, 2024
Benzinga Insights
-
Feb 26, 2024, 4:47AM
Friday, February 23, 2024
A Preview Of Staar Surgical's Earnings
Benzinga Insights
-
Feb 23, 2024, 10:01AM
Tuesday, January 23, 2024
STAAR Surgical And SharpeVision Announced A Strategic Agreement To Provide EVO ICL Lenses As A First Choice For Patients Seeking Visual Freedom From Contact Lenses And Glasses
Benzinga Newsdesk
-
Jan 23, 2024, 7:03AM
Thursday, January 11, 2024
Insiders Buying KalVista Pharmaceuticals And 3 Other Stocks
Avi Kapoor
-
Jan 11, 2024, 6:40AM
Monday, January 08, 2024
STAAR Surgical shares are trading higher after the company issued preliminary Q4 and FY23 net sales guidance above estimates.
Benzinga Newsdesk
-
Jan 8, 2024, 12:36PM
$6.5M Bet On This Healthcare Stock? Check Out These 3 Stocks Insiders Are Buying
Avi Kapoor
-
Jan 8, 2024, 7:13AM
STAAR Surgical Repots Preliminary Net Sales Of $76.5M (est. $74.23M) For Q4 And Approximately $322.5M (Est. $320.5M) For FY23
Benzinga Newsdesk
-
Jan 8, 2024, 7:07AM
Tuesday, December 05, 2023
Needham Downgrades Staar Surgical to Hold
Benzinga Newsdesk
-
Dec 5, 2023, 8:06AM
Monday, December 04, 2023
Analyst Ratings for Staar Surgical
Benzinga Insights
-
Dec 4, 2023, 2:00PM
Morgan Stanley Initiates Coverage On Staar Surgical with Equal-Weight Rating, Announces Price Target of $35
Benzinga Newsdesk
-
Dec 4, 2023, 7:58AM
Friday, December 01, 2023
Eye On Growth: BROADWOOD PARTNERS LP Adds $13.70M Of Staar Surgical Stock To Portfolio
Benzinga Insights
-
Dec 1, 2023, 10:01AM
Wednesday, November 15, 2023
Staar Surgical 10% Owner Trades Company's Stock
Benzinga Insights
-
Nov 15, 2023, 10:04AM
Friday, November 10, 2023
9.66M Reasons To Be Bullish On Staar Surgical Stock
Benzinga Insights
-
Nov 10, 2023, 10:02AM
Over $13M Bet On This Energy Stock? Check Out These 4 Stocks Insiders Are Buying
Lisa Levin
-
Nov 10, 2023, 8:52AM
Tuesday, November 07, 2023
10.80M Reasons To Be Bullish On Staar Surgical Stock
Benzinga Insights
-
Nov 7, 2023, 10:03AM
More Than $10M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying
Lisa Levin
-
Nov 7, 2023, 6:33AM
Thursday, November 02, 2023
Piper Sandler Maintains Neutral on Staar Surgical, Lowers Price Target to $40
Benzinga Newsdesk
-
Nov 2, 2023, 4:02PM
The Latest Analyst Ratings for Staar Surgical
Benzinga Insights
-
Nov 2, 2023, 3:00PM
Why STAAR Surgical Shares Are Trading Lower By Around 16%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Lisa Levin
-
Nov 2, 2023, 2:26PM
Staar Surgical shares are trading lower following Q3 results.
Benzinga Newsdesk
-
Nov 2, 2023, 12:22PM
Needham Maintains Buy on Staar Surgical, Lowers Price Target to $49
Benzinga Newsdesk
-
Nov 2, 2023, 6:52AM
Wednesday, November 01, 2023
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga Insights
-
Nov 1, 2023, 5:31PM
Staar Surgical Q3 2023 Adj EPS $0.30 Beats $0.18 Estimate, Sales $80.31M Miss $80.32M Estimate
Benzinga Newsdesk
-
Nov 1, 2023, 4:02PM
Earnings Scheduled For November 1, 2023
Benzinga Insights
-
Nov 1, 2023, 7:19AM
Wednesday, October 25, 2023
Shares of healthcare equipment and tools stocks are trading lower in sympathy with Thermo Fisher and Danaher.
Benzinga Newsdesk
-
Oct 25, 2023, 3:03PM
Monday, October 09, 2023
Over $8M Bet On Howard Hughes? Check Out These 4 Stocks Insiders Are Buying
Lisa Levin
-
Oct 9, 2023, 6:39AM
Tuesday, October 03, 2023
Stocks That Hit 52-Week Lows On Tuesday
Benzinga Insights
-
Oct 3, 2023, 2:37PM
Monday, September 25, 2023
Insiders Buying Blackstone, STAAR Surgical And 2 Other Stocks
Lisa Levin
-
Sep 25, 2023, 8:01AM
Friday, September 22, 2023
10% Owner of Staar Surgical Makes $11.69M Buy
Benzinga Insights
-
Sep 22, 2023, 11:02AM
Stifel Maintains Hold on Staar Surgical, Lowers Price Target to $40
Benzinga Newsdesk
-
Sep 22, 2023, 9:24AM
Show more
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch